Eva Doleželová

614 total citations
18 papers, 453 citations indexed

About

Eva Doleželová is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Eva Doleželová has authored 18 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Eva Doleželová's work include Trypanosoma species research and implications (11 papers), Biochemical and Molecular Research (10 papers) and HIV/AIDS drug development and treatment (9 papers). Eva Doleželová is often cited by papers focused on Trypanosoma species research and implications (11 papers), Biochemical and Molecular Research (10 papers) and HIV/AIDS drug development and treatment (9 papers). Eva Doleželová collaborates with scholars based in Czechia, United States and Australia. Eva Doleželová's co-authors include Michal Žurovec, David Doležel, Jeffrey C. Hall, Peter J. Bryant, Tomáš Doležal, Alena Zı́ková, Hans‐Peter Nothacker, Olivier Civelli, Dana Hocková and Luke W. Guddat and has published in prestigious journals such as Nucleic Acids Research, Journal of Neuroscience and Scientific Reports.

In The Last Decade

Eva Doleželová

18 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Doleželová Czechia 9 183 159 137 98 74 18 453
J.L. Dutton Australia 14 81 0.4× 488 3.1× 112 0.8× 115 1.2× 75 1.0× 20 834
Yufang Chao United States 7 114 0.6× 145 0.9× 24 0.2× 39 0.4× 14 0.2× 9 451
Benjamin A. Adler United States 16 204 1.1× 472 3.0× 86 0.6× 28 0.3× 69 0.9× 26 912
Akane Ohta Japan 16 69 0.4× 120 0.8× 254 1.9× 93 0.9× 41 0.6× 30 579
Gabriel Aughey United Kingdom 11 62 0.3× 421 2.6× 14 0.1× 72 0.7× 40 0.5× 16 496
Chang‐Su Lim United States 7 36 0.2× 256 1.6× 197 1.4× 62 0.6× 21 0.3× 8 648
Daniela Vorkel Germany 9 82 0.4× 245 1.5× 30 0.2× 23 0.2× 59 0.8× 10 514
Chantal Wicky Switzerland 13 45 0.2× 499 3.1× 39 0.3× 216 2.2× 166 2.2× 21 861
Manuel A. Garcia United States 12 60 0.3× 223 1.4× 9 0.1× 79 0.8× 35 0.5× 12 691
S.J. Goodson United Kingdom 8 150 0.8× 542 3.4× 13 0.1× 25 0.3× 170 2.3× 11 893

Countries citing papers authored by Eva Doleželová

Since Specialization
Citations

This map shows the geographic impact of Eva Doleželová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Doleželová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Doleželová more than expected).

Fields of papers citing papers by Eva Doleželová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Doleželová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Doleželová. The network helps show where Eva Doleželová may publish in the future.

Co-authorship network of co-authors of Eva Doleželová

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Doleželová. A scholar is included among the top collaborators of Eva Doleželová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Doleželová. Eva Doleželová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Keough, Dianne T., Gordon J. King, Radek Pohl, et al.. (2024). Development of Prolinol Containing Inhibitors of Hypoxanthine–Guanine–Xanthine Phosphoribosyltransferase: Rational Structure-Based Drug Design. Journal of Medicinal Chemistry. 67(9). 7158–7175. 3 indexed citations
2.
Keough, Dianne T., Gordon J. King, Eva Doleželová, et al.. (2022). Stereo-Defined Acyclic Nucleoside Phosphonates are Selective and Potent Inhibitors of Parasite 6-Oxopurine Phosphoribosyltransferases. Journal of Medicinal Chemistry. 65(5). 4030–4057. 7 indexed citations
3.
Doleželová, Eva, et al.. (2022). Synthesis and anti-trypanosomal evaluation of novel N-branched acyclic nucleoside phosphonates bearing 7-aryl-7-deazapurine nucleobase. European Journal of Medicinal Chemistry. 239. 114559–114559. 2 indexed citations
4.
Doleželová, Eva, Petr Pachl, Lenka Poštová Slavětínská, et al.. (2021). C1′-Branched acyclic nucleoside phosphonates mimicking adenosine monophosphate: Potent inhibitors of Trypanosoma brucei adenine phosphoribosyltransferase. European Journal of Medicinal Chemistry. 225. 113798–113798. 4 indexed citations
5.
Doleželová, Eva, et al.. (2021). Acyclic nucleoside phosphonates with adenine nucleobase inhibit Trypanosoma brucei adenine phosphoribosyltransferase in vitro. Scientific Reports. 11(1). 13317–13317. 7 indexed citations
6.
Perlíková, Pavla, Eva Doleželová, Lenka Poštová Slavětínská, et al.. (2021). Synthesis and Antitrypanosomal Activity of 6-Substituted 7-Methyl-7-deazapurine Nucleosides. ACS Infectious Diseases. 7(4). 917–926. 5 indexed citations
7.
Tichý, Michal, Radek Pohl, Eva Doleželová, et al.. (2021). Synthesis and anti-trypanosomal activity of 3′-fluororibonucleosides derived from 7-deazapurine nucleosides. Bioorganic & Medicinal Chemistry Letters. 40. 127957–127957. 5 indexed citations
8.
Doleželová, Eva, Mario Dejung, Michal Levin, et al.. (2020). Cell-based and multi-omics profiling reveals dynamic metabolic repurposing of mitochondria to drive developmental progression of Trypanosoma brucei. PLoS Biology. 18(6). e3000741–e3000741. 27 indexed citations
9.
Smith, Joseph T., Eva Doleželová, Jonathan Bard, et al.. (2020). Developmental regulation of edited CYb and COIII mitochondrial mRNAs is achieved by distinct mechanisms in Trypanosoma brucei. Nucleic Acids Research. 48(15). 8704–8723. 11 indexed citations
10.
Doleželová, Eva, et al.. (2019). Crystal structures of Trypanosoma brucei hypoxanthine – guanine – xanthine phosphoribosyltransferase in complex with IMP, GMP and XMP. FEBS Journal. 286(23). 4721–4736. 9 indexed citations
11.
Doleželová, Eva, Ondřej Gahura, Dianne T. Keough, et al.. (2018). Evaluation of the Trypanosoma brucei 6-oxopurine salvage pathway as a potential target for drug discovery. PLoS neglected tropical diseases. 12(2). e0006301–e0006301. 41 indexed citations
12.
Knight, David, Philip J. Harvey, Konstantin G. Iliadi, et al.. (2010). Equilibrative Nucleoside Transporter 2 Regulates Associative Learning and Synaptic Function inDrosophila. Journal of Neuroscience. 30(14). 5047–5057. 28 indexed citations
13.
Doleželová, Eva, David Doležel, & Jeffrey C. Hall. (2007). Rhythm Defects Caused by Newly Engineered Null Mutations in Drosophila's cryptochrome Gene. Genetics. 177(1). 329–345. 126 indexed citations
14.
Hall, J. C., D.C. Chang, & Eva Doleželová. (2007). Principles and Problems Revolving Round Rhythm-related Genetic Variants. Cold Spring Harbor Symposia on Quantitative Biology. 72(1). 215–232. 2 indexed citations
15.
Doleželová, Eva, Hans‐Peter Nothacker, Olivier Civelli, Peter J. Bryant, & Michal Žurovec. (2007). A Drosophila adenosine receptor activates cAMP and calcium signaling. Insect Biochemistry and Molecular Biology. 37(4). 318–329. 61 indexed citations
16.
Doleželová, Eva, et al.. (2006). Use of two transcription starts in the G6PD gene of the bark beetle Ips typographus. Insect Molecular Biology. 15(1). 25–32. 4 indexed citations
17.
Doležal, Tomáš, Eva Doleželová, Michal Žurovec, & Peter J. Bryant. (2005). A Role for Adenosine Deaminase in Drosophila Larval Development. PLoS Biology. 3(7). e201–e201. 81 indexed citations
18.
Doleželová, Eva, Michal Žurovec, Tomáš Doležal, Petr Šimek, & Peter J. Bryant. (2005). The emerging role of adenosine deaminases in insects. Insect Biochemistry and Molecular Biology. 35(5). 381–389. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026